The Gross Margin of Navidea Biopharmaceuticals Inc (NAVB) is -171.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | -171.43% |
| 2021-12-31 | 100.00% |
| 2020-12-31 | 98.91% |
| 2019-12-31 | 98.48% |
| 2018-12-31 | 91.45% |
| 2017-12-31 | 100.00% |
| 2016-12-31 | 98.79% |
| 2015-12-31 | 86.72% |
| 2014-12-31 | 74.80% |
| 2013-12-31 | 70.80% |